Skip to main content
. 2015 Jul 28;63(6):596–600. doi: 10.7727/wimj.2014.016

Table. Genotypic resistance profile of the protease and reverse transcriptase (Pro-RT) region of the HIV genome illustrating major and minor mutations in addition to other mutations that were detected.

Sample ID NRTI mutations NNRTI mutations PI mutations Other mutations Pro-RT CD4 count Antiretroviral treatment
PM1005VJ0040NA K103S, G190A I13V, L63P, K70R, V179I 209 Drug naive
PM1005VJ0050 I15V, M36I, L63P, L210M 497 Experienced
PM1005VJ0051NA A71AT M36V, I62V, L63P 260 Drug naive
PM1005VJ0054NA I13V, L63P 762 Drug naive
PM1005VJ0056 I15V, M36I, L63P, K70R ND Experienced
PM1005VJ0066NA K219EK A71V L63PS, I93L 701 Drug naive
PM1005VJ0055 K103N I13V, L63P, I64L, V77I 403 Experienced
PM1005VJ0067NA T69S I15V, M36V, K70R 19 Drug naive
PM1005VJ0068 A71T I13V, I62V, L63P, V77I 603 Experienced

NRTI – nucleoside reverse transcriptase inhibitor;

NNRTI – non-nucleoside reverse transcriptase inhibitor;

PI – protease inhibitor;

ND – no data